Our team tracked more than $370M in health innovation funding reported this week, led by InferVision, a Philadelphia, PA-based medical AI provider specializing in the clinical application of AI and deep learning technologies. InferVision raised $140M in total from Series D1 and D2 financing, with the Series D2 led by Goldman Sachs Asset Management. <source>

Other recent deals included:

AllStripes, a San Francisco, CA-based health tech company dedicated to unlocking treatments for people affected by rare diseases, raised $50M led by Lux Capital, with participation from JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and angel investors including Arif Nathoo and Leila Zegna. <source>

Ultromics, an Oxford, UK-based AI-enabled cardiovascular imaging solutions provider, raised $33M led by Blue Venture Fund, with participation from Optum Ventures, GV, and Oxford Sciences Innovation. <source>